These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report.
    Author: Kristensen KL, Dragsted UB.
    Journal: Scand J Infect Dis; 2014 Jan; 46(1):63-5. PubMed ID: 23957539.
    Abstract:
    The ability of Plasmodium vivax to relapse is a challenge to its management. Primaquine is the only drug licensed for the eradication of hypnozoites. We report the case of a non-immune traveller, who required high dosage primaquine treatment to obtain radical cure of vivax malaria, emphasizing the importance of country-specific and weight-based dosing of primaquine.
    [Abstract] [Full Text] [Related] [New Search]